Page last updated: 2024-09-03

n(omega)-hydroxyarginine and Breast Cancer

n(omega)-hydroxyarginine has been researched along with Breast Cancer in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (66.67)	29.6817
2010's	2 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Avliyakulov, NK; Braga, M; Chaudhuri, G; Haykinson, MJ; Martinez, L; Parveen, M; Pervin, S; Singh, R; Singh, V	1
Aloj, SM; Chiaviello, A; Paciello, I; Palumbo, G; Veneziani, BM	1
Chaudhuri, G; Pervin, S; Singh, R	2
Cederbaum, S; Chaudhuri, G; Karimi, A; Pervin, S; Singh, R	1
Chaudhuri, G; Pervin, S; Singh, R; Wu, G	1

Reviews

1 review(s) available for n(omega)-hydroxyarginine and Breast Cancer

Article	Year
Nitric oxide, N omega-hydroxy-L-arginine and breast cancer. Nitric oxide : biology and chemistry, 2008, Volume: 19, Issue:2 Topics: Apoptosis; Arginine; Breast Neoplasms; Cell Cycle Proteins; Cell Proliferation; Female; Humans; Nitric Oxide	2008

Other Studies

5 other study(ies) available for n(omega)-hydroxyarginine and Breast Cancer

Article	Year
Proteomic identification of mitochondrial targets of arginase in human breast cancer. PloS one, 2013, Volume: 8, Issue:11 Topics: Animals; Apoptosis; Arginase; Arginine; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Electrophoresis, Gel, Two-Dimensional; Female; Glycine Hydroxymethyltransferase; Humans; Mass Spectrometry; Mice; Mice, Nude; Middle Aged; Mitochondria; Mitochondrial Proteins; Proteomics; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Transplantation, Heterologous; Tumor Burden	2013
Cells derived from normal or cancer breast tissue exhibit different growth properties when deprived of arginine. Medical oncology (Northwood, London, England), 2012, Volume: 29, Issue:4 Topics: Arginine; Breast; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Eflornithine; Female; Humans	2012
Caspase-8-mediated BID cleavage and release of mitochondrial cytochrome c during Nomega-hydroxy-L-arginine-induced apoptosis in MDA-MB-468 cells. Antagonistic effects of L-ornithine. The Journal of biological chemistry, 2002, Oct-04, Volume: 277, Issue:40 Topics: Apoptosis; Arginine; BH3 Interacting Domain Death Agonist Protein; Breast Neoplasms; Carrier Proteins; Caspase 8; Caspase 9; Caspases; Cytochrome c Group; Female; Humans; Intracellular Membranes; Kinetics; Membrane Potentials; Mitochondria; Tumor Cells, Cultured	2002
Arginase activity in human breast cancer cell lines: N(omega)-hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells. Cancer research, 2000, Jun-15, Volume: 60, Issue:12 Topics: Apoptosis; Arginase; Arginine; Blotting, Western; Breast Neoplasms; Caspase 3; Caspases; Cell Cycle; Cell Division; DNA Fragmentation; Enzyme Inhibitors; Flow Cytometry; Humans; In Situ Nick-End Labeling; Nitric Oxide; Nitric Oxide Synthase; Ornithine; Reverse Transcriptase Polymerase Chain Reaction; Spermine; Tumor Cells, Cultured	2000
Activation of caspase-3 activity and apoptosis in MDA-MB-468 cells by N(omega)-hydroxy-L-arginine, an inhibitor of arginase, is not solely dependent on reduction in intracellular polyamines. Carcinogenesis, 2001, Volume: 22, Issue:11 Topics: Adenosylmethionine Decarboxylase; Apoptosis; Arginase; Arginine; Blotting, Western; Breast Neoplasms; Caspase 3; Caspases; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Enzyme Activation; Enzyme Inhibitors; Humans; In Situ Nick-End Labeling; Ornithine; Ornithine Decarboxylase; Polyamines; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured	2001